Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -100.00% vs 0.00% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 7.78% vs 50.50% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is 9.20% vs 366.84% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 31.42% vs 22.45% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 68.21% vs -48.48% in Mar 2025
Compare Balance Sheet Results of Jenburkt Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.41
13.56
-9.15
-67.48%
Share Warrants & Outstandings
Total Reserve
192.63
257.55
-64.92
-25.21%
Shareholder's Funds
197.04
279.73
-82.69
-29.56%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.78
-0.78
-100.00%
Secured Loans
0.00
0.78
-0.78
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-1.42
-3.21
1.79
55.76%
Other Long Term Liabilities
4.85
0.00
4.85
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
2.37
-2.37
-100.00%
Total Non-Current Liabilities
3.43
-0.07
3.50
5,000.00%
Current Liabilities
Trade Payables
8.10
37.63
-29.53
-78.47%
Other Current Liabilities
8.45
4.18
4.27
102.15%
Short Term Borrowings
0.00
36.16
-36.16
-100.00%
Short Term Provisions
6.59
0.68
5.91
869.12%
Total Current Liabilities
23.15
78.65
-55.50
-70.57%
Total Liabilities
223.61
358.30
-134.69
-37.59%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
38.39
142.36
-103.97
-73.03%
Less: Accumulated Depreciation
26.85
58.52
-31.67
-54.12%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
11.55
83.84
-72.29
-86.22%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
46.12
0.00
46.12
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
27.02
8.06
18.96
235.24%
Long Term Loans & Advances
3.64
4.96
-1.32
-26.61%
Other Non Current Assets
32.28
55.33
-23.05
-41.66%
Total Non-Current Assets
128.52
152.19
-23.67
-15.55%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
13.63
70.08
-56.45
-80.55%
Sundry Debtors
24.36
64.91
-40.55
-62.47%
Cash and Bank
53.11
31.08
22.03
70.88%
Other Current Assets
1.97
1.71
0.26
15.20%
Short Term Loans and Advances
2.01
38.34
-36.33
-94.76%
Total Current Assets
95.09
206.12
-111.03
-53.87%
Net Current Assets (Including Current Investments)
71.94
127.47
-55.53
-43.56%
Total Current Assets Excluding Current Investments
95.09
206.12
-111.03
-53.87%
Miscellaneous Expenses not written off
0.00
6.62
-6.62
-100.00%
Total Assets
223.61
358.30
-134.69
-37.59%
Contingent Liabilities
17.20
0.00
17.20
0.00%
Total Debt
0.00
36.93
-36.93
-100.00%
Book Value per share (adjusted)
446.47
199.90
246.57
123.35%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -100.00% vs 0.00% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 4.85 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 7.78% vs 50.50% in Mar 2025
Annual - Fixed Assets
Fixed Assets 57.66 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 9.20% vs 366.84% in Mar 2025
Annual - Investments
Investments 27.02 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 31.42% vs 22.45% in Mar 2025
Annual - Current Assets
Current Assets 95.09 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 68.21% vs -48.48% in Mar 2025
Footer loading
